The effect of hexadecylphosphocholine on the degradation of mitochondrial phospholipids.
Hexadecylphosphocholine (HePC) is known as antitumor agent but the mechanism has not yet been understood. In rat liver mitochondria its effect on phospholipid transformation has been studied by quantitative HPTLC and phosphorus determination. From the results it can be concluded that HePC influences the activities of phospholipase A2, phospholipase C, phospholipase D, and lysophospholipase A. The phospholipid transformation as well as the influence of HePC are affected by exogenous calcium ions. In the presence of calcium HePC has been found to inhibit enzyme activities, whereas in the absence of exogenous calcium ions enzymatic phospholipid transformations are activated or inhibited depending on HePC concentrations.
Vagina
O
O
Department of Biophysics, Faculty of Biology, Tashkent State University, Uzbekistan.
Gellerich
F N
FN
Ulbrich-Hofmann
R
R
D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002855:Chromatography, Thin Layer / Q000379:methods; D004305:Dose-Response Relationship, Drug; D008930:Mitochondria, Liver / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism*; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D010743:Phospholipids; D010767:Phosphorylcholine; C039128:miltefosine; D002118:Calcium